VANCOUVER, British Columbia — On October 20, 2026, Cannabix Technologies Inc. revealed that it has successfully completed the first commercial delivery of its innovative breath-based multi-drug testing panel. This new testing technology is designed to identify recent drug use, aligning itself with standards similar to those used by the Department of Transportation in Canada and elsewhere.
Cannabix, which specializes in developing marijuana and alcohol testing technologies, aims to create a reliable option for employers and organizations seeking to implement effective drug testing protocols. The new panel is seen as a significant advancement in the ability to detect recent substance use in individuals, which can be particularly useful in workplace settings where safety is a priority.
The introduction of this breath-based testing panel is expected to contribute to increased workplace safety and might change the landscape of drug testing by providing rapid and non-invasive testing methods. Cannabix Technologies continues to invest in research and development to improve its product offerings in the field of drug detection technology.
Analyzed Canadian Outlets (1)
1 headline